Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Бейсъново кохортно изследване× | Анализ на преживяемостта× | |
|---|---|---|
| Област≠ | Дизайн на изследването | Статистика за изследвания |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | Formalised in health research from the 1990s onward | 1958 |
| Създател≠ | Synthesis of cohort epidemiology (Doll & Hill, 1950s) with Bayesian inference (Bayes, Laplace, Jeffreys) | Edward L. Kaplan and Paul Meier |
| Тип≠ | Quantitative longitudinal observational design | Method |
| Основополагащ източник≠ | Ibrahim, J. G., & Chen, M. H. (2000). Power prior distributions for regression models. Statistical Science, 15(1), 46–60. DOI ↗ | Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI ↗ |
| Други названия≠ | Bayesian cohort study, Bayesian prospective cohort, Bayesian longitudinal cohort analysis, Bayesian follow-up study | Kaplan-Meier analysis, Cox regression, TTE analysis |
| Свързани≠ | 4 | 3 |
| Резюме≠ | Bayesian cohort research follows a defined group of individuals over time to track outcomes, and uses Bayesian statistical inference to update beliefs about risk, incidence, or causal effects as follow-up data accumulate. Prior knowledge — from earlier studies, registries, or expert judgment — is formalised into a prior distribution and combined with the cohort's likelihood to yield a posterior distribution that quantifies uncertainty in a directly interpretable way. | Survival analysis is a collection of statistical methods for modeling time from a defined starting point until an event of interest occurs (disease, recovery, death, equipment failure). Kaplan and Meier's nonparametric estimator (1958) and David Cox's proportional hazards model (1972) jointly enabled analysis of censored data—individuals whose event times are unknown because they left the study or were still event-free at follow-up. Indispensable in oncology, cardiology, infectious disease research, engineering reliability, and any field where time-to-event matters. |
| ScholarGateНабор от данни ↗ |
|
|